Other Income & Expense

Gains on strategic investments, net

Thermo Fisher Scientific Gains on strategic investments, net decreased by 150.0% to -$1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 150.0%, from $2.00M to -$1.00M.

Analysis

StatementIncome Statement
SectionOther Income & Expense
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
Metric ID: crm_gains_on_strategic_investments_net

Historical Data

11 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q1 '26
Value-$1.00M$25.00M-$139.00M$17.00M-$13.00M-$44.00M$11.00M$10.00M-$4.00M$2.00M-$1.00M
QoQ Change>999%-656.0%+112.2%-176.5%-238.5%+125.0%-9.1%-140.0%+150.0%-150.0%
YoY Change>999%-152.0%+68.3%+184.6%+122.7%-136.4%-80.0%-150.0%
Range-$139.00M$25.00M
CAGR+0.0%
Avg YoY Growth+207.2%
Median YoY Growth-5.8%

Gains on strategic investments, net at Other Companies

Frequently Asked Questions

What is Thermo Fisher Scientific's gains on strategic investments, net?
Thermo Fisher Scientific (TMO) reported gains on strategic investments, net of -$1.00M in Q1 2026.
How has Thermo Fisher Scientific's gains on strategic investments, net changed year-over-year?
Thermo Fisher Scientific's gains on strategic investments, net decreased by 150.0% year-over-year, from $2.00M to -$1.00M.